Royal London Asset Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
35.4%
This Fund
S&P 500
1 Year Est. Return
+35.4%
AUM
$47.5B
AUM Growth
+$1B
(+2.2%)
Holding
708
Top Buys
| 1 | +$135M | |
| 2 | +$117M | |
| 3 | +$115M | |
| 4 |
Qualcomm
QCOM
|
+$92.4M |
| 5 |
APi Group
APG
|
+$76M |
Top Sells
| 1 | +$171M | |
| 2 | +$138M | |
| 3 | +$128M | |
| 4 |
Microsoft
MSFT
|
+$91.4M |
| 5 |
Amazon
AMZN
|
+$89.4M |
Sector Composition
| 1 | Technology | 33.18% |
| 2 | Financials | 13.62% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Communication Services | 9.99% |
| 5 | Healthcare | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Liberty Live Group Series C
LLYVK
$8.7B
| $83 | ﹤0.01% |
1
|
|
||
702
Liberty Global Class C
LBTYK
$3.98B
| $11 | ﹤0.01% |
1
|
|
||
|
RAL
703
Ralliant Corp
RAL
$5.11B
| – | – |
-51,454
|
|
||
|
K
704
DELISTED
Kellanova
K
| – | – |
-165,884
|
|
||
705
Infosys
INFY
$50.5B
| – | – |
-50,063
|
|
||
706
Crown Holdings
CCK
$11.2B
| – | – |
-5,302
|
|
||
707
BioMarin Pharmaceuticals
BMRN
$10.4B
| – | – |
-4,196
|
|
||
708
Akamai
AKAM
$15.3B
| – | – |
-6,332
|
|